🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Secondary Immune Deficiency

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers NCT06580574Phase 21 site📍 Beijing Peking University · Tests: PD1/PDL1 antibody monotherapy, up to 24 weeks, Intensive immunotherapy plus anti-VEGF treatment, up to 24 weeks, Radica… Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies NCT07648264Phase 360 sites📍 Orange📍 Denver📍 Coral Springs CSL Behring · Tests: IgPro20 Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency NCT05879757n/a27 sites📍 Córdoba📍 Pilsen📍 Prague Takeda · Tests: No Intervention HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention) NCT06513819Phase 11 site📍 West Haven Yale University · Tests: Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma NCT07582432Phase 35 sites📍 St. Petersburg📍 Fort Wayne📍 Westbrook Grifols Biologicals, LLC · Tests: Gamunex-C, 10% Injectable Solution Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) NCT01666080NA1 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Busulfan, Fludarabine, Total body irradiation, Stem cell transplant, Keppra A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma NCT06980480Phase 365 sites📍 Mobile📍 Orange📍 Westwood Takeda · Tests: IGI, 10% Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project NCT06821880n/a5 sites📍 Innsbruck📍 Graz📍 Kufstein Medical University Innsbruck Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension NCT05678621Phase 2, Phase 37 sites📍 Garran📍 Concord📍 St Leonards Monash University · Tests: trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic acid and ciprofloxacin, Immunoglobulins SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy NCT06989541n/a1 site📍 Edmonton University of Alberta · Tests: Immune Globulin Intravenous (Human), 10%, Immune Globulin Subcutaneous (Human), 20% Solution National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy